Skip to content
healthcare.dev

Atgam

NDC 0009-7224, EQUINE THYMOCYTE IMMUNE GLOBULIN, injection, solution, from Pharmacia & Upjohn Company LLC.

Product NDC
0009-7224
Status
Listed
Labeler
Pharmacia & Upjohn Company LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA103676
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0009-7224 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EQUINE THYMOCYTE IMMUNE GLOBULIN50 mg/mL

Pharmacologic classes

Antibody-Surface Protein Interactions [MoA]; Immunoglobulin G [EPC]; Immunoglobulins [CS]; Increased T Lymphocyte Destruction [PE]; Lymphocyte Function Alteration [PE]

Package NDCNDC-11Package
0009-7224-02000097224025 AMPULE in 1 CARTON (0009-7224-02) / 5 mL in 1 AMPULE (0009-7224-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0009-7224

Use it

Look up 0009-7224 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0009-7224 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0009-7224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.